Thursday, July 29, 2021 1:21:07 AM
File Date Form Security Prev
Shares Current
Shares Change
(Percent) Ownership
(Percent) Change
(Percent)
2021-01-15 13G INTRACOASTAL CAPITAL, LLC 3,749,923 4.99
2021-01-15 13G CVI Investments, Inc. 3,800,000 5.30
2021-01-14 13G Empery Asset Management, LP 3,800,000 5.32
More recent filings..
2021-05-13 13F Renaissance Technologies Llc 1.53 3,304,140 570.48 6,972 1,389.74
2021-05-14 13F Vanguard Group Inc 1.53 3,180,565 513.88 6,711 1,264.02
2021-06-01 NP VTSMX - Vanguard Total Stock Market Index Fund Investor Shares [click for advisory] 2,080,920 4,391
2021-05-07 13F BlackRock Inc. 1.80 1,532,282 228,940.66 3,233 323,200.00
2021-06-01 NP VEXMX - Vanguard Extended Market Index Fund Investor Shares [click for advisory] 1,000,089 2,110
2021-05-12 13F Geode Capital Management, Llc 1.53 488,114 442.93 1,029 1,110.59
2021-05-17 13F Cvi Holdings, Llc 432,305 912
2021-07-22 NP FSMAX - Fidelity Extended Market Index Fund [click for advisory] 362,917 1,169
2021-05-19 13F Virtu Financial LLC 1.53 271,937 -1.22 574 119.08
2021-05-17 13F Sabby Management, Llc 242,237 511
2021-05-17 13F Morgan Stanley 1.06 197,733 732,244.44 418
2021-05-12 13F Northern Trust Corp 1.52 145,648 1,258.53 307 2,970.00
2021-05-18 13F Jane Street Group, Llc 94,810 200
2021-07-22 NP FSKAX - Fidelity Total Market Index Fund [click for advisory] 88,019 283
2021-07-19 13F Cutler Group LP 4.20 72,179 63.94 456 395.65
2021-05-13 13F Barclays Plc 1.52 65,694 455.69 139 1,163.64
2021-05-17 13F Goldman Sachs Group Inc 63,770 135
2021-06-01 NP VITNX - Vanguard Institutional Total Stock Market Index Fund Institutional Shares [click for advisory] 60,800 128
2021-07-22 NP FNCMX - Fidelity Nasdaq Composite Index Fund [click for advisory] 60,434 195
2021-07-22 NP FCFMX - Fidelity Series Total Market Index Fund [click for advisory] 58,337 188
2021-05-14 13F Sculptor Capital LP 53,500 113
2021-05-17 13F Capstone Investment Advisors, Llc 51,257 108
2021-05-17 13F Edmond De Rothschild Holding S.a. 50,000 106
2021-05-17 13F Susquehanna International Group, Llp 1.53 49,256 -54.16 104 1.96
2021-04-30 13F Creative Planning 48,666 103
2021-05-17 13F Two Sigma Advisers, Lp 1.52 48,400 348.15 102 920.00
2021-07-26 13F Spire Wealth Management 4.55 48,000 6.67 335 252.63
2021-05-13 13F Bank of New York Mellon Corp 35,927 76
2021-05-21 13F/A Citadel Advisors Llc 1.54 34,070 -22.12 72 71.43
2021-05-04 13F Commonwealth Equity Services, Llc 31,383 66
2021-05-06 13F Meitav Dash Investments Ltd 30,000 63
2021-05-17 13F Bienville Capital Management, LLC 28,379
https://fintel.io/so/us/atos
Recent ATOS News
- Atossa Therapeutics Announces Support of Final Rule from FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer • GlobeNewswire Inc. • 09/10/2024 12:30:00 PM
- Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 12:30:00 PM
- Atossa Therapeutics Granted Additional Patent Protection for Endoxifen • GlobeNewswire Inc. • 08/28/2024 12:30:00 PM
- Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Combining (Z)-Endoxifen with Abemaciclib for ER+/HER2- Breast Cancer • GlobeNewswire Inc. • 08/21/2024 12:30:00 PM
- Atossa Therapeutics Announces the Appointment of Michael Parks as Vice President, Investor and Public Relations • GlobeNewswire Inc. • 08/20/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 01:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 01:00:09 PM
- Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/12/2024 12:30:00 PM
- Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer • GlobeNewswire Inc. • 07/22/2024 12:30:00 PM
- Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer • GlobeNewswire Inc. • 07/02/2024 08:15:00 PM
- Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer • GlobeNewswire Inc. • 06/28/2024 12:30:00 PM
- Atossa Set to Join Russell 3000® Index Effective June 28, 2024 • GlobeNewswire Inc. • 06/17/2024 12:30:00 PM
- Atossa to Present at the Sidoti Small-Cap Investor Conference • GlobeNewswire Inc. • 06/05/2024 12:30:00 PM
- Atossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast Cancer Risk Assessment Model • GlobeNewswire Inc. • 05/28/2024 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/24/2024 04:15:32 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/23/2024 01:00:04 PM
- Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial • GlobeNewswire Inc. • 05/15/2024 12:30:00 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 05/14/2024 08:46:30 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/13/2024 08:05:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 01:05:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 01:00:12 PM
- Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2024 12:50:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/10/2024 01:00:05 PM
- Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines • GlobeNewswire Inc. • 05/07/2024 12:30:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM